Phase 1 oncology biotech developing small molecule inhibitor therapies.
Industry: Health Care
First Day Return: +100.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/05/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.8 |
Deal Size ($mm) | $125 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/25/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $125 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2016 |
Employees at IPO | 33 |
Website www.ikenaoncology.com |